19,99 €
inkl. MwSt.

Versandfertig in 6-10 Tagen
payback
10 °P sammeln
  • Broschiertes Buch

High Quality Content by WIKIPEDIA articles! Qiagen (NASDAQ: QGEN, FWB: QIA) is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. Consolidated under the Dutch holding Qiagen N.V., the company operates more than 30 subsidiaries in over 18 countries. Qiagen's shares are listed at the technology-focused U.S. stock exchange Nasdaq (using ticker QGEN) and at the Frankfurt Stock Exchange in the Prime Standard (using ticker QIA). Peer M. Schatz is the company's Chief Executive Officer. The main headquarters are located in…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
High Quality Content by WIKIPEDIA articles! Qiagen (NASDAQ: QGEN, FWB: QIA) is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. Consolidated under the Dutch holding Qiagen N.V., the company operates more than 30 subsidiaries in over 18 countries. Qiagen's shares are listed at the technology-focused U.S. stock exchange Nasdaq (using ticker QGEN) and at the Frankfurt Stock Exchange in the Prime Standard (using ticker QIA). Peer M. Schatz is the company's Chief Executive Officer. The main headquarters are located in Hilden, Germany (near Düsseldorf). Formerly, the company was recognized as a provider of sample technologies for the academic research market. Today, Qiagen's product portfolio includes sample and assay technologies along with specific automation solutions for these technologies in the following markets: molecular diagnostics, applied testing, academic and pharmaceutical research. Qiagen's products enable processing of biological samples and targeted detection of genetic material.